Literature DB >> 26130295

Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration.

José Bustos-Arriaga1,2, Neida K Mita-Mendoza3, Moises Lopez-Gonzalez1, Julio García-Cordero1, Francisco J Juárez-Delgado4, Gregory D Gromowski2, René A Méndez-Cruz5, Rick M Fairhurst3, Stephen S Whitehead2, Leticia Cedillo-Barrón6.   

Abstract

When dengue virus (DENV)-infected mosquitoes use their proboscis to probe into human skin during blood feeding, both saliva and virus are released. During this process, cells from the epidermis and dermis layers of the skin, along with small blood vessels, may get exposed to or infected with DENV. In these microenvironments of the skin, the presence of DENV initiates a complex interplay among the DENV-infected and non-infected neighboring cells at the initial bite site. Previous studies suggested that DENV-infected human dermal fibroblasts (HDFs) participate in the immune response against DENV by secreting soluble mediators of innate immunity. In the present study, we investigated whether DENV-infected HDFs activate human dermal microvascular endothelial cells (HDMECs) in co-cultures. Our results suggest that co-cultures of DENV-infected HDFs and HDMECs elicit soluble mediators that are sufficient to reduce viral replication, activate HDMECs, and induce leukocyte migration through HDMEC monolayers. These effects were partly dependent on HDF donor and DENV serotype, which may provide novel insights into the natural variation in host susceptibility to DENV disease.

Entities:  

Keywords:  Cellular crosstalk; Dengue; Fibroblast and endothelial cells; Innate immunity; Skin

Mesh:

Substances:

Year:  2016        PMID: 26130295     DOI: 10.1007/s12026-015-8675-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  55 in total

1.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Cross-talk between dendritic cells and natural killer cells in viral infection.

Authors:  Daniel M Andrews; Christopher E Andoniou; Anthony A Scalzo; Serani L H van Dommelen; Morgan E Wallace; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

3.  Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.

Authors:  Pornapat Surasombatpattana; Rodolphe Hamel; Sirilaksana Patramool; Natthanej Luplertlop; Frédéric Thomas; Philippe Desprès; Laurence Briant; Hans Yssel; Dorothée Missé
Journal:  Infect Genet Evol       Date:  2011-06-21       Impact factor: 3.342

4.  Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.

Authors:  Christopher E Andoniou; Serani L H van Dommelen; Valentina Voigt; Daniel M Andrews; Geraldine Brizard; Carine Asselin-Paturel; Thomas Delale; Katryn J Stacey; Giorgio Trinchieri; Mariapia A Degli-Esposti
Journal:  Nat Immunol       Date:  2005-09-04       Impact factor: 25.606

5.  Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.

Authors:  Ana B Perez; Beatriz Sierra; Gissel Garcia; Eglis Aguirre; Nina Babel; Mayling Alvarez; Licel Sanchez; Luis Valdes; Hans D Volk; Maria G Guzman
Journal:  Hum Immunol       Date:  2010-08-21       Impact factor: 2.850

6.  Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors.

Authors:  P Génin; M Algarté; P Roof; R Lin; J Hiscott
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

7.  Human three-dimensional fibroblast cultures express angiogenic activity.

Authors:  E Pinney; K Liu; B Sheeman; J Mansbridge
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

8.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

9.  Activation of the innate immune response against DENV in normal non-transformed human fibroblasts.

Authors:  José Bustos-Arriaga; Jazmín García-Machorro; Moisés León-Juárez; Julio García-Cordero; Leopoldo Santos-Argumedo; Leopoldo Flores-Romo; A René Méndez-Cruz; Francisco J Juárez-Delgado; Leticia Cedillo-Barrón
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

Review 10.  Vascular endothelium: the battlefield of dengue viruses.

Authors:  Atanu Basu; Umesh C Chaturvedi
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-03
View more
  2 in total

1.  Variability in Susceptibility to Type I Interferon Response and Subgenomic RNA Accumulation Between Clinical Isolates of Dengue and Zika Virus From Oaxaca Mexico Correlate With Replication Efficiency in Human Cells and Disease Severity.

Authors:  Tannya Karen Castro-Jiménez; Laura Cristina Gómez-Legorreta; Laura Alejandra López-Campa; Valeria Martínez-Torres; Marcos Alvarado-Silva; Araceli Posadas-Mondragón; Nallely Díaz-Lima; Hilda Arcelia Angulo-Mendez; Nancy R Mejía-Domínguez; Felipe Vaca-Paniagua; Federico Ávila-Moreno; Julio García-Cordero; Leticia Cedillo-Barrón; Sergio Roberto Aguilar-Ruíz; José Bustos-Arriaga
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

2.  Crosstalk Between Dermal Fibroblasts and Dendritic Cells During Dengue Virus Infection.

Authors:  Alfredo E Montes-Gómez; Julio García-Cordero; Edith Marcial-Juárez; Gaurav Shrivastava; Giovani Visoso-Carvajal; Francisco J Juárez-Delgado; Leopoldo Flores-Romo; Ma Carmen Sanchez-Torres; Leopoldo Santos-Argumedo; José Bustos-Arriaga; Leticia Cedillo-Barrón
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.